Skip to content

Yoga and quality of life study

A randomized controlled clinical trial to investigate whether practising Yoga improves the quality of life for gynaecological cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN61120944
Enrollment
54
Registered
2013-07-23
Start date
2011-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynaecological cancer Cancer Malignant neoplasms of female genital organs

Interventions

A gentle course of Hatha Yoga vs standard care The classes lasted for one hour and patients attend once a week for 10 weeks. The control group had care as normal. Both groups were followed up (compl

Sponsors

University of Derby (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 18 or above 2. Diagnosed with cancer of the ovary, cervix, vulva, fallopian tube, or peritoneum 3. Undergoing treatment or about to undergo treatment in the form of surgery, chemotherapy or radiotherapy (or a mixture of these) 4. Able to engage with a gentle programme of yoga

Exclusion criteria

Exclusion criteria: 1. Diagnosed with a benign condition such as ovarian cyst 2. Patients with the mental incapacity not to be able to give informed consent 3. Patients unable to understand verbal or written English 4. Patients who already practice yoga who would be unwilling to enter the control arm of the trial

Design outcomes

Primary

MeasureTime frame
1. Quality of Life measured using the European Organisation for Research and treatment of Cancer 2. Quality of Life Questionnaire Core 30 measured Pre/Post intervention and at 4 month follow up.

Secondary

MeasureTime frame
1. Mental Adjustment to Cancer measured Pre/Post intervention and at 4 month follow up. 2. Acceptance of Illness measured Pre/Post intervention and at 4 month follow up. 3. Pain, anxiety and Fatigue measured on a weekly basis whilst on the trial, measured using the Visual Analogue Scale (VAS) score (0 = no pain, 10 = unbearable pain)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026